DUBLIN, Sept. 9, 2022 /PRNewswire/ — The “Brain Cancer Diagnostics Market Forecast to 2028 – COVID-19 Impact and Global Analysis by Diagnostic Type; Cancer Type; End-user; and Tumor Size” report has been added to ResearchAndMarkets.com’s offering.
The global brain cancer diagnostics market is expected to grow from US$ 1,639.10 million in 2022 to US$ 7,378.57 million by 2028.
The increase in brain cancer worldwide and the rise in cigarette smokers boost the growth of the global brain cancer diagnostics market.
Cancer Research UK estimated that around 12,288 new cases of brain, other CNS, and intracranial tumors are diagnosed in the UK each year, which makes it around 34 cases per day (2016-2018). Brain tumors, other central nervous systems, and intracranial tumors are the ninth most common malignancies in the UK, accounting for 3% of all new cancer cases (2016-2018). Also, it is the 7th most common cancer in females in the UK, with around 6,400 new cases during 2016-2018 . Similarly, in males, brain, other CNS, and intracranial tumors are the 11th most common cancer, with about 5,800 new cases in the UK during 2016-2018. Incidence rates for brain tumors are highest in people aged 85 to 89 (2016- 2018) in the UK.
According to the American Association of Neurological Surgeons, glioblastoma is the most common malignant brain and other CNS tumor, accounting for 47.7% of all cases; the incidence of glioblastoma is 3.21 per 100,000 …